RxDoctor Payments Data

Thomas Malbrough, MD

Physical Medicine & Rehabilitation · Festus, MONPI 1609193937

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Zyla Life Sciences, Inc. at 24.0% of the total. Reporting peaked in 2019 at $532 and has fallen 96.3% since, to $20 in 2024.

$1,157in general payments, 2019–2025

Across 90 payments — averaging $12.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zyla Life Sciences, Inc.$278
  • Nevro Corp.$149
  • Scilex Pharmaceuticals Inc.$139
  • Sentynl Therapeutics, Inc.$120
  • Amgen$88
  • Abbott$69
  • plus $314 from 13 others

What the payments were for

  • Food & beverage$1,157100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,157 in reported general payments places this provider in the 75th percentile of 182 physical medicine & rehabilitation providers in Missouri.

See all physical medicine & rehabilitation providers in Missouri

Medicare billing

Part B allowed, 2024
$71,754
Medicare patients
298
Services billed
628

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen91$1,905
Gabapentin69$672
Methocarbamol45$482
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$411
Methylprednisolone20$151
Tizanidine Hcl27$98
Diclofenac Sodium16$75
Tramadol Hcl16$74
Meloxicam29$59
Alprazolam44$54
Ibuprofen14$49

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Festus

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →